Dergiler / Turkish Journal of Gastroenterology / 2018 / Cilt: 29 - Sayı: 4

Hepatic fine-needle aspiration cytology: The role of rapid on-site evaluation in the assessment of hepatic lesions

Sayfa
442–447
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

With the application of ROSE, there was a statistically significant increase in the diagnostic yield of hepatic FNACs from 86.25% to 95.8% (p=0.015).Conclusion: ROSE performed by a cytopathologist using toluidine blue can increase the diagnostic yield of hepatic FNACs and reduce the cost of healthcare by eliminating the need for a repeat procedure.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Radiologically guided fine-needle aspiration cytology (FNAC) of internal organs is not cost-effective.
📊
Temel Bulgular & Veri:Rapid on-site evaluation (ROSE) of smears by a cytopathologist can improve the diagnostic yield of FNACs and save time and money by reducing the need for repeat procedure/biopsy.
💡
Sonuç & Katkı:With the application of ROSE, there was a statistically significant increase in the diagnostic yield of hepatic FNACs from 86.25% to 95.8% (p=0.015).Conclusion: ROSE performed by a cytopathologist using toluidine blue can increase the diagnostic yield of hepatic FNACs and reduce the cost of healthcare by eliminating the need for a repeat procedure.
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Radiologically guided fine-needle aspiration cytology (FNAC) of internal organs is not cost-effective. Rapid on-site evaluation (ROSE) of smears by a cytopathologist can improve the diagnostic yield of FNACs and save time and money by reducing the need for repeat procedure/biopsy. To determine the role of ROSE in the diagnostic outcome of hepatic lesions by comparative analysis of FNAC with and without ROSE by a cytopathologist.Materials and Methods: Hepatic FNACs were retrospectively analyzed over two separate time periods from January 2011 to June 2013 and from January 2015 to July 2016. Smears from 2015-2016 were subjected to ROSE by a cytopathologist after staining with tolui-dine blue for 1 min to assess adequacy of the material. Final report was given after hematoxylin and eosin, May Grünwald Giemsa, and Papanicolaou staining were performed. Chi-square test (non-parametric) was used to determine if there was a statistically significant increase in the diagnostic yield with ROSE.Results: During 2011-2013, of the 160 radiologically guided FNACs for hepatic lesions, 22 were non-diagnostic, whereas during 2015-2016, of 142 radiologically guided hepatic FNACs, only six were non-diagnostic. With the application of ROSE, there was a statistically significant increase in the diagnostic yield of hepatic FNACs from 86.25% to 95.8% (p=0.015).Conclusion: ROSE performed by a cytopathologist using toluidine blue can increase the diagnostic yield of hepatic FNACs and reduce the cost of healthcare by eliminating the need for a repeat procedure.

🔖

Bu Makaleye Atıf Yap

SELHI, P. K., TYAGI, R., BANSAL, P., KAUR, H., SOOD, N. (2018). Hepatic fine-needle aspiration cytology: The role of rapid on-site evaluation in the assessment of hepatic lesions. Turkish Journal of Gastroenterology, Cilt: 29 - Sayı: 4, 442–447. https://ajindex.com/articles/410138

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Collins JA, Novak A, Ali SZ, Olson MT. Cytotechnologists and on- site evaluation of adequacy. Korean J Pathol 2013; 47: 405-10.
  2. Baloch ZW, Tam D, Langer J, Mandel S, Livolsi LA, Gupta PK. Ul- trasound-guided fine-needle aspiration biopsy of the thyroid: Role of on-site assessment and multiple cytologic preparations. Diagn Cytopathol 2000; 23: 425-9.
  3. Nasuti JF, Gupta PF, Baloch ZW. Diagnostic value and cost-effec- tiveness of on-site evaluation of fine-needle aspiration specimens: Review of 5688 cases. Diagn Cytopathol 2002; 27: 1-4.
  4. Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine needle aspiration smears. A cost and compensation analysis. Cancer 2001; 93: 319-22.
  5. Ramzy I, Omran DA, Fouab A, Khatab H, El- Etreby R. Rapid on- Site Evaluation of Ultrasound-Guided Fine Needle Aspiration of He- patic Masses. Med J Cairo Univ 2010; 78: 133-7.
  6. Petrone MC, Arcidiacono PG. Basic technique in endoscopic ul- trasound guided fine needle aspiration for solid lesions: How many passes? Endosc Ultrasound 2014; 3: 22-7.
  7. Saleh HA, Khatib G. Positive economic and diagnostic accuracy impacts of on-site evaluation of fine needle aspiration biopsies by pathologists. Acta Cytol 1996; 40: 1227-30.
  8. Iglesias Garcia J, Larino Noia J, Abdulkader I, Dominguez Munoz JE. Rapid on-site evaluation of endoscopic-ultrasound-guided fine needle aspiration diagnosis of pancreatic masses. World J Gastro- enterol 2014; 20: 9451-7.
  9. Sindhwani G, Rawat J, Chandra S, Kusum A, Rawat M. Transbron- chial needle aspiration with rapid on-site evaluation: a prospective study on efficacy, feasibility and cost effectiveness. Indian J Chest Dis Allied Sci 2013; 55: 141-4.
  10. Klapman JB, Logrono R, Dye CE, et al. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol 2003; 98: 1289-94.
  11. Iglesias-Garcia J, Dominguez-Munoz JE, Abdulkader I, et al. Influ- ence of on-site cytopathology evaluation on the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of solid pancreatic masses. Am J Gastroenterol 2011; 106: 1705-10.
  12. Polkowski M, Larghi A, Weynand B, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endosco- py (ESGE) Technical Guideline. Endoscopy 2012; 44: 190-206.
  13. Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnos